Dutch public health experts refute claims that human papillomavirus vaccination has health risks

BMJ ◽  
2009 ◽  
Vol 338 (mar17 3) ◽  
pp. b1109-b1109 ◽  
Author(s):  
T. Sheldon
2019 ◽  
Vol 6 (4) ◽  
pp. 317-326
Author(s):  
Gui-Dan Tang ◽  
Gu-Qing Zeng ◽  
Bi-Xia Zhao ◽  
Yun-Li Li ◽  
Rong Wang ◽  
...  

Abstract Objectives To systematically review the knowledge attitudes and the influential factors on human papillomavirus (HPV) vaccination among Chinese women. Methods Published studies on knowledge and attitudes of HPV vaccination for preventing cervical cancer among Chinese female population were retrieved using the major Chinese and English databases. Meanwhile, handwork retrieval was also conducted and the references including in the literature were retrieved. The quality of the literature was rigorously evaluated and extracted independently by two researchers and the data were analyzed and described by review manager 5.3 (RevMan5.3) software. Results In all, 19 articles including 8 articles in Chinese and 11 in English were chosen. A total of 30,176 participants were included and the sample size ranged from 64 to 6,024. The overall awareness of HPV and HPV vaccine among Chinese women was at a low level. Chinese women generally showed poor knowledge about HPV and HPV vaccine. Acceptance of HPV vaccination among Chinese women was at a high level. Vaccination intentions were influenced by the theory of planned behavior (TPB) and measured by attitudes subjective norms and perceived behavioral control. Conclusions The health authorities may evaluate and develop TPB-based interventions to increase HPV vaccination intentions of Chinese women. HPV vaccination programs should focus on carrying out multi-level and targeted health education and developing effective public health strategies after balancing the cost and benefit of HPV vaccine program. Medical staff should play the positive role in promoting the use of HPV vaccines in China. Integration of policy and community perspectives and multi-level interventions are essential to maximize the public health benefits of HPV vaccination.


2016 ◽  
Vol 214 (6) ◽  
pp. 854-861 ◽  
Author(s):  
Suzette M. Matthijsse ◽  
Jan A. C. Hontelez ◽  
Steffie K. Naber ◽  
Kirsten Rozemeijer ◽  
Inge M. C. M. de Kok ◽  
...  

2021 ◽  
pp. 100014
Author(s):  
Jordan Birebent ◽  
Aurore Palmaro ◽  
Céline Tanios-Dulot ◽  
Damien Driot ◽  
Julie Dupouy ◽  
...  

2011 ◽  
Vol 57 (1) ◽  
pp. 149-158
Author(s):  
Abdelkader El Hasnaoui ◽  
Nadia Demarteau ◽  
Denis Granados ◽  
Baudouin Standaert ◽  
Bruno Detournay

2020 ◽  
Vol 25 (Supplement_1) ◽  
pp. S16-S20 ◽  
Author(s):  
Nicholas Chadi ◽  
Claudia Minato ◽  
Richard Stanwick

Abstract The rapid emergence of youth vaping has completely changed the landscape of adolescent substance use in Canada and has become a pressing public health issue of our time. While nicotine remains the most common substance encountered in vaping devices, cannabis vaping is now reported by one-third of youth who vape. Though cannabis vaping is thought to generate fewer toxic emissions than cannabis smoking, it has been associated with several cases of acute lung injury and often involves high-potency forms of cannabis, exposing youth to several acute and long-term health risks. The low perceived riskiness of cannabis as a substance and of vaping as a mode of consumption may bring a false sense of security and be particularly appealing for youth who may be looking for a ‘healthier way’ to use substances. While research is still lacking on how best to support youth who may have already initiated cannabis vaping, concerted efforts among paediatric providers, public health experts, schools, communities, and families are urgently needed to limit the spread of cannabis vaping among Canadian youth.


Sign in / Sign up

Export Citation Format

Share Document